keyboard_arrow_up

Environmental Testing and Clinical Testing Market to Reach US$2.1 bn by 2022 due to Globally Rising Spread and High Morbidity Rates of E. Coli

A new Transparency Market Research report states that the global E. coli testing market stood at US$1.2 bn in 2013 .and is predicted to reach US$2.1 bn by 2022. It is expected to expand at a CAGR of 6.58% from 2014 to 2022. The title of the report is, “E.coli Testing (Environmental Testing and Clinical Testing) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.” 

Escherichia coli (E. coli) are a diverse and large group of bacteria found in the environment, several foods, and intestines of animals and peoplehumans. Although the majority of strains of E. coli aren’t harmful, others can cause intestinal infections. The key symptoms of an E. coli infection include abdominal pain, diarrhea, and kidney failure. People having weakened immune systems, older adults, young children, and pregnant women are at a high risk of developing such complications. The kinds of E. coli that cause diarrhea are transmitted via contaminated food or water or via contact with affected persons or animals.

As per the report, the increasing initiatives taken by governments in favor of E. coli tests and the rising spread and high morbidity of E. coli are amongst the prime factors driving the growth of the market for E. coli testing. In addition, the development of drug-resistant species is also having a positive impact on the growth of the market. Polymerase chain reaction (PCR) tests being used for environment water testing has emerged as a key growth opportunity in the market. On the other hand, the soaring prices of enzyme-substrate tests in comparison with separate apparatus tests are inhibiting the growth of the market.

In terms of testing method, the report segments the market into clinical testing and environmental testing. The segment of environmental testing is further segmented into membrane filtration (MF), enzyme-substrate methods, and multiple tube fermentation (MTF). On the other hand, the segment of clinical testing is further segmented into enzyme immunoassays (EIA), polymerase chain reaction (PCR) tests, and others. Amongst these, on the basis of revenue, the segment of enzyme substrate tests hold the largest share of 80% in the market. On the basis of volume, this segment constitutes a share of 40% in the market. In terms of revenue, the segment of membrane filtration holds the largest share in the market.

On the basis of end use, the report segments the market into clinical and environmental. The segment of clinical E. coli testing is further segmented into diagnostic laboratories, hospitals, and physician offices. The segment of environmental E-coli testing is further segmented into bottle water suppliers, home and drinking water suppliers, waste water treatment organizations, and others including private well owners, government agencies, farm water testing, and groundwater testing, among others. Amongst these, E. coli testing has been highly demanded by bottle water suppliers and home and drinking water suppliers.

Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4822

Geographically, the market is segmented into Europe, North America, Latin America, Africa, Rest of Africa, Asia Pacific, and Rest of the World (RoW). Amongst these, Europe led the market in 2013 due to the outbreak of foodborne infections within Germany in 2011 due to the E. coli O104:H4 strain. On the other hand, Asia Pacific is anticipated to be the most lucrative region in the market and is predicted to rise at a 6.92% CAGR from 2014 to 2022. This is owing to the increasing water pollution in rising economies such as India, Japan, and China.

According to the report, the key players dominant in the market are Danaher Corporation, Abbott Laboratories, Enzo Life Sciences, Inc., Bio-Rad Laboratories, and Hologic, among others.